Browsing Tag
European Union
123 posts
Enhertu EU approval : Daiichi Sankyo, AstraZeneca get approval for HER2 low metastatic breast cancer
Daiichi Sankyo and AstraZeneca have received the approval of the European Union (EU) for their jointly developed Enhertu…
January 29, 2023
Takeda gets QDENGA EC approval as dengue vaccine
Takeda has received the European Commission’s (EC) marketing authorization for the company’s dengue vaccine QDENGA (Dengue Tetravalent Vaccine…
December 12, 2022
EU launches full-scale investigation into Microsoft, Activision deal
The European Commission has launched a full-scale phase 2 investigation to evaluate the previously announced acquisition of Activision…
November 11, 2022
Virax Biolabs Group rolls out Monkeypox Virus Antigen Rapid Test Kits
UK-based Virax Biolabs Group Limited has started distribution of Monkeypox Virus Antigen Rapid Test Kits, which were launched…
September 27, 2022
PDS Limited subsidiary Poetic Brands signs licensing deal for Forever 21
PDS Limited, an Indian consumer-driven manufacturing and sourcing company, said that its UK-based subsidiary Poetic Brands has signed…
June 5, 2022
Cara Therapeutics, VFMCRP get EC approval for Kapruvia for pruritus
Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) said that Kapruvia (difelikefalin) has secured approval from…
May 1, 2022
Windlas Biotech secures EU GMP approval for Dehradun Plant-IV with zero critical observations
Windlas Biotech’s Dehradun Plant-IV earns EU GMP approval with zero critical observations, unlocking new opportunities in European regulated markets.
April 15, 2022
SeQuent Scientific gets EU GMP approval for tablets dosage form in Turkey
SeQuent Scientific Limited said that its tablets dosage manufacturing line in Turkey has secured the European Union good…
July 15, 2021
Sedana Medical seeks approval for Sedaconda in Europe, eyes inhaled sedation for ICU patients
Sedana Medical, a prominent player in the field of medical sedatives, has officially submitted an application for regulatory…
November 29, 2020
Bristol Myers Squibb’s Opdivo receives EC approval for second-line treatment of ESCC
Bristol Myers Squibb (BMS) has achieved a significant milestone with the approval of its immunotherapy drug, Opdivo (nivolumab),…
November 24, 2020